Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis
2013 StandoutNobel
Chapter 3 Biology of the Eosinophil
2009
Schistosoma mansoni infection in eosinophil lineage–ablated mice
2006
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner
2003
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Protective immune mechanisms in helminth infection
2007 Standout
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
2014 Standout
The Inflammatory Response to Cardiopulmonary Bypass: Part 1—Mechanisms of Pathogenesis
2008
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
IgE and mast cells in allergic disease
2012 Standout
Adult patients with Eisenmenger syndrome report flying safely on commercial airlines
2006
Nonresolving Inflammation
2010 Standout
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger???s Syndrome
2008
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches?
2011
Asthma
2017 Standout
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases
2004
Eosinophils: changing perspectives in health and disease
2012
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Cerebrovascular accidents in adult patients with congenital heart disease
2010
Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab
2008
Thrombin During Cardiopulmonary Bypass
2006
Plasma Tissue Factor Plus Activated Peripheral Mononuclear Cells Activate Factors VII and X in Cardiac Surgical Wounds
2005
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
2014 Standout
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass
2007
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome
2009
Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension
2011
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
IgE, mast cells, basophils, and eosinophils
2010 Standout
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2018
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Immunological and hematological effects of IL ‐5(Rα)‐targeted therapy: An overview
2018
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Pulmonary Vascular Disease in Adults With Congenital Heart Disease
2007
Chronic Heart Failure in Congenital Heart Disease
2016
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease
2013
Tissue Factor: An Enzyme Cofactor and a True Receptor
2001
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of John Burman being referenced
Seeking Optimal Relation Between Oxygen Saturation and Hemoglobin Concentration in Adults With Cyanosis from Congenital Heart Disease
2011
Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics
2003
Blood Viscosity and its Relationship to Iron Deficiency, Symptoms, and Exercise Capacity in Adults With Cyanotic Congenital Heart Disease
2006
Pulmonary Arterial Thrombosis in Eisenmenger Syndrome Is Associated With Biventricular Dysfunction and Decreased Pulmonary Flow Velocity
2007
Two-Chain Factor VIIa Generated in the Pericardium During Surgery With Cardiopulmonary Bypass
1999
Tissue Factor Is Rapidly Elevated in Plasma Collected from the Pericardial Cavity during Cardiopulmonary Bypass
2000